0001209191-16-149330.txt : 20161110
0001209191-16-149330.hdr.sgml : 20161110
20161110161436
ACCESSION NUMBER: 0001209191-16-149330
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161109
FILED AS OF DATE: 20161110
DATE AS OF CHANGE: 20161110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friedman Michael A
CENTRAL INDEX KEY: 0001298083
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 161988200
MAIL ADDRESS:
STREET 1: 28903 NORTH AVENUE PAINE
CITY: VALENCIA
STATE: CA
ZIP: 91355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-09
0
0000816284
CELGENE CORP /DE/
CELG
0001298083
Friedman Michael A
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
1
0
0
0
Common Stock
2016-11-09
4
M
0
18600
31.80
A
18600
D
Common Stock
2016-11-09
4
S
0
18600
116.10
D
0
D
Common Stock
14199
I
Family Trust
Stock Option (right to buy)
31.80
2016-11-09
4
M
0
18600
D
2022-06-13
Common Stock
18600
0
D
The shares were sold by the reporting person pursuant to a Rule 10b5-1 plan.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The option was fully exercisable.
The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015).
/s/Mark J. Alles _________________________________________________________
Mark J. Alles, Attorney-in-Fact
2016-11-09